1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Raltegravir 1.2.3 Elvitegravir Combination Drugs 1.2.4 Dolutegravir and Its Combination Drug 1.2.5 Bictegravir Combination Drug 1.2.6 Cabotegravir 1.2.7 Other 1.3 Market by Application 1.3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Drug Center 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Perspective (2016-2027) 2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Growth Trends by Regions 2.2.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Share by Regions (2016-2021) 2.2.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Regions (2022-2027) 2.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Dynamic 2.3.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Trends 2.3.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Drivers 2.3.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Challenges 2.3.4 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Revenue 3.1.1 Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Revenue (2016-2021) 3.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Players (2016-2021) 3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue 3.4 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Ratio 3.4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in 2020 3.5 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players Head office and Area Served 3.6 Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Product Solution and Service 3.7 Date of Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 HIV Integrase Strand Transfer Inhibitors (INSTI) Breakdown Data by Type 4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Type (2016-2021) 4.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Type (2022-2027) 5 HIV Integrase Strand Transfer Inhibitors (INSTI) Breakdown Data by Application 5.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Application (2016-2021) 5.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) 6.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type 6.2.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) 6.2.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027) 6.2.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2027) 6.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application 6.3.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) 6.3.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027) 6.3.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2027) 6.4 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country 6.4.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021) 6.4.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) 7.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type 7.2.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) 7.2.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027) 7.2.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2027) 7.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application 7.3.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) 7.3.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027) 7.3.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2027) 7.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country 7.4.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021) 7.4.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) 8.2 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type 8.2.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2027) 8.3 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application 8.3.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2027) 8.4 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region 8.4.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) 9.2 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type 9.2.1 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) 9.2.2 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027) 9.2.3 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2027) 9.3 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application 9.3.1 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) 9.3.2 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027) 9.3.3 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2027) 9.4 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country 9.4.1 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021) 9.4.2 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027) 10.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type 10.2.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2027) 10.3 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application 10.3.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2027) 10.4 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country 10.4.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Adcock Ingram Limited 11.1.1 Adcock Ingram Limited Company Details 11.1.2 Adcock Ingram Limited Business Overview 11.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.1.4 Adcock Ingram Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.1.5 Adcock Ingram Limited Recent Development 11.2 Affine Formulations Limited 11.2.1 Affine Formulations Limited Company Details 11.2.2 Affine Formulations Limited Business Overview 11.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.2.4 Affine Formulations Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.2.5 Affine Formulations Limited Recent Development 11.3 Aurobindo Pharma 11.3.1 Aurobindo Pharma Company Details 11.3.2 Aurobindo Pharma Business Overview 11.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.3.4 Aurobindo Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.3.5 Aurobindo Pharma Recent Development 11.4 Biocon Limited 11.4.1 Biocon Limited Company Details 11.4.2 Biocon Limited Business Overview 11.4.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.4.4 Biocon Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.4.5 Biocon Limited Recent Development 11.5 Bristol-Myers Squibb 11.5.1 Bristol-Myers Squibb Company Details 11.5.2 Bristol-Myers Squibb Business Overview 11.5.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.5.4 Bristol-Myers Squibb Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.5.5 Bristol-Myers Squibb Recent Development 11.6 Cipla 11.6.1 Cipla Company Details 11.6.2 Cipla Business Overview 11.6.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.6.4 Cipla Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.6.5 Cipla Recent Development 11.7 Emcure Pharmaceuticals 11.7.1 Emcure Pharmaceuticals Company Details 11.7.2 Emcure Pharmaceuticals Business Overview 11.7.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.7.4 Emcure Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.7.5 Emcure Pharmaceuticals Recent Development 11.8 Flamingo Pharmaceuticals Limited 11.8.1 Flamingo Pharmaceuticals Limited Company Details 11.8.2 Flamingo Pharmaceuticals Limited Business Overview 11.8.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.8.4 Flamingo Pharmaceuticals Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.8.5 Flamingo Pharmaceuticals Limited Recent Development 11.9 Gilead Sciences 11.9.1 Gilead Sciences Company Details 11.9.2 Gilead Sciences Business Overview 11.9.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.9.4 Gilead Sciences Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.9.5 Gilead Sciences Recent Development 11.10 Hetero Drugs 11.10.1 Hetero Drugs Company Details 11.10.2 Hetero Drugs Business Overview 11.10.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.10.4 Hetero Drugs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.10.5 Hetero Drugs Recent Development 11.11 IPCA Laboratories 11.11.1 IPCA Laboratories Company Details 11.11.2 IPCA Laboratories Business Overview 11.11.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.11.4 IPCA Laboratories Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.11.5 IPCA Laboratories Recent Development 11.12 Janssen Pharmaceutica (Johnson & Johnson) 11.12.1 Janssen Pharmaceutica (Johnson & Johnson) Company Details 11.12.2 Janssen Pharmaceutica (Johnson & Johnson) Business Overview 11.12.3 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.12.4 Janssen Pharmaceutica (Johnson & Johnson) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.12.5 Janssen Pharmaceutica (Johnson & Johnson) Recent Development 11.13 LAURUS Labs 11.13.1 LAURUS Labs Company Details 11.13.2 LAURUS Labs Business Overview 11.13.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.13.4 LAURUS Labs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.13.5 LAURUS Labs Recent Development 11.14 Medisist Pharma 11.14.1 Medisist Pharma Company Details 11.14.2 Medisist Pharma Business Overview 11.14.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.14.4 Medisist Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.14.5 Medisist Pharma Recent Development 11.15 Merck 11.15.1 Merck Company Details 11.15.2 Merck Business Overview 11.15.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.15.4 Merck Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.15.5 Merck Recent Development 11.16 Mylan 11.16.1 Mylan Company Details 11.16.2 Mylan Business Overview 11.16.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.16.4 Mylan Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.16.5 Mylan Recent Development 11.17 Ranbaxy Pharmaceuticals 11.17.1 Ranbaxy Pharmaceuticals Company Details 11.17.2 Ranbaxy Pharmaceuticals Business Overview 11.17.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.17.4 Ranbaxy Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.17.5 Ranbaxy Pharmaceuticals Recent Development 11.18 Shanghai Desano Pharmaceuticals 11.18.1 Shanghai Desano Pharmaceuticals Company Details 11.18.2 Shanghai Desano Pharmaceuticals Business Overview 11.18.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction 11.18.4 Shanghai Desano Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) 11.18.5 Shanghai Desano Pharmaceuticals Recent Development 11.18 ViiV Healthcare (GSK) .1 ViiV Healthcare (GSK) Company Details .2 ViiV Healthcare (GSK) Business Overview .3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction .4 ViiV Healthcare (GSK) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) .5 ViiV Healthcare (GSK) Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Raltegravir Table 3. Key Players of Elvitegravir Combination Drugs Table 4. Key Players of Dolutegravir and Its Combination Drug Table 5. Key Players of Bictegravir Combination Drug Table 6. Key Players of Cabotegravir Table 7. Key Players of Other Table 8. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Regions (2016-2021) & (US$ Million) Table 11. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions (2016-2021) Table 12. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 13. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions (2022-2027) Table 14. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Trends Table 15. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Drivers Table 16. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Challenges Table 17. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Restraints Table 18. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Players (2016-2021) & (US$ Million) Table 19. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Players (2016-2021) Table 20. Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2020) Table 21. Ranking of Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Companies by Revenue (US$ Million) in 2020 Table 22. Global 5 Largest Players Market Share by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (CR5 and HHI) & (2016-2021) Table 23. Key Players Headquarters and Area Served Table 24. Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Product Solution and Service Table 25. Date of Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) (US$ Million) Table 28. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2016-2021) Table 29. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 30. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 31. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Share by Application (2016-2021) & (US$ Million) Table 32. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Application (2016-2021) Table 33. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 34. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 35. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) (US$ Million) Table 36. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027) & (US$ Million) Table 37. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) (US$ Million) Table 38. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027) & (US$ Million) Table 39. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021) & (US$ Million) Table 40. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) & (US$ Million) Table 41. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) (US$ Million) Table 42. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027) & (US$ Million) Table 43. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) (US$ Million) Table 44. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027) & (US$ Million) Table 45. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021) & (US$ Million) Table 46. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) & (US$ Million) Table 47. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) (US$ Million) Table 48. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027) & (US$ Million) Table 49. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) (US$ Million) Table 50. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027) & (US$ Million) Table 51. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2016-2021) & (US$ Million) Table 52. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2022-2027) & (US$ Million) Table 53. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) (US$ Million) Table 54. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027) & (US$ Million) Table 55. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) (US$ Million) Table 56. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027) & (US$ Million) Table 57. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021) & (US$ Million) Table 58. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) & (US$ Million) Table 59. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) (US$ Million) Table 60. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027) & (US$ Million) Table 61. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) (US$ Million) Table 62. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027) & (US$ Million) Table 63. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021) & (US$ Million) Table 64. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) & (US$ Million) Table 65. Adcock Ingram Limited Company Details Table 66. Adcock Ingram Limited Business Overview Table 67. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 68. Adcock Ingram Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 69. Adcock Ingram Limited Recent Development Table 70. Affine Formulations Limited Company Details Table 71. Affine Formulations Limited Business Overview Table 72. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 73. Affine Formulations Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 74. Affine Formulations Limited Recent Development Table 75. Aurobindo Pharma Company Details Table 76. Aurobindo Pharma Business Overview Table 77. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 78. Aurobindo Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 79. Aurobindo Pharma Recent Development Table 80. Biocon Limited Company Details Table 81. Biocon Limited Business Overview Table 82. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 83. Biocon Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 84. Biocon Limited Recent Development Table 85. Bristol-Myers Squibb Company Details Table 86. Bristol-Myers Squibb Business Overview Table 87. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 88. Bristol-Myers Squibb Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 89. Bristol-Myers Squibb Recent Development Table 90. Cipla Company Details Table 91. Cipla Business Overview Table 92. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 93. Cipla Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 94. Cipla Recent Development Table 95. Emcure Pharmaceuticals Company Details Table 96. Emcure Pharmaceuticals Business Overview Table 97. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 98. Emcure Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 99. Emcure Pharmaceuticals Recent Development Table 100. Flamingo Pharmaceuticals Limited Company Details Table 101. Flamingo Pharmaceuticals Limited Business Overview Table 102. Flamingo Pharmaceuticals Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 103. Flamingo Pharmaceuticals Limited Recent Development Table 104. Gilead Sciences Company Details Table 105. Gilead Sciences Business Overview Table 106. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 107. Gilead Sciences Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 108. Gilead Sciences Recent Development Table 109. Hetero Drugs Company Details Table 110. Hetero Drugs Business Overview Table 111. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 112. Hetero Drugs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 113. Hetero Drugs Recent Development Table 114. IPCA Laboratories Company Details Table 115. IPCA Laboratories Business Overview Table 116. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 117. IPCA Laboratories Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 118. IPCA Laboratories Recent Development Table 119. Janssen Pharmaceutica (Johnson & Johnson) Company Details Table 120. Janssen Pharmaceutica (Johnson & Johnson) Business Overview Table 121. Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 122. Janssen Pharmaceutica (Johnson & Johnson) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 123. Janssen Pharmaceutica (Johnson & Johnson) Recent Development Table 124. LAURUS Labs Company Details Table 125. LAURUS Labs Business Overview Table 126. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 127. LAURUS Labs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 128. LAURUS Labs Recent Development Table 129. Medisist Pharma Company Details Table 130. Medisist Pharma Business Overview Table 131. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 132. Medisist Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 133. Medisist Pharma Recent Development Table 134. Merck Company Details Table 135. Merck Business Overview Table 136. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 137. Merck Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 138. Merck Recent Development Table 139. Mylan Company Details Table 140. Mylan Business Overview Table 141. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 142. Mylan Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 143. Mylan Recent Development Table 144. Ranbaxy Pharmaceuticals Company Details Table 145. Ranbaxy Pharmaceuticals Business Overview Table 146. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 147. Ranbaxy Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 148. Ranbaxy Pharmaceuticals Recent Development Table 149. Shanghai Desano Pharmaceuticals Company Details Table 150. Shanghai Desano Pharmaceuticals Business Overview Table 151. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 152. Shanghai Desano Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 153. Shanghai Desano Pharmaceuticals Recent Development Table 154. ViiV Healthcare (GSK) Company Details Table 155. ViiV Healthcare (GSK) Business Overview Table 156. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Table 157. ViiV Healthcare (GSK) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million) Table 158. ViiV Healthcare (GSK) Recent Development Table 159. Research Programs/Design for This Report Table 160. Key Data Information from Secondary Sources Table 161. Key Data Information from Primary Sources List of Figures Figure 1. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type: 2020 VS 2027 Figure 2. Raltegravir Features Figure 3. Elvitegravir Combination Drugs Features Figure 4. Dolutegravir and Its Combination Drug Features Figure 5. Bictegravir Combination Drug Features Figure 6. Cabotegravir Features Figure 7. Other Features Figure 8. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application: 2020 VS 2027 Figure 9. Hospital Case Studies Figure 10. Clinic Case Studies Figure 11. Drug Center Case Studies Figure 12. Other Case Studies Figure 13. HIV Integrase Strand Transfer Inhibitors (INSTI) Report Years Considered Figure 14. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions: 2020 VS 2027 Figure 17. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions (2022-2027) Figure 18. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Players in 2020 Figure 19. Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2020 Figure 20. The Top 10 and 5 Players Market Share by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in 2020 Figure 21. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2016-2021) Figure 22. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2022-2027) Figure 23. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2016-2027) Figure 25. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2016-2027) Figure 26. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2016-2027) Figure 27. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2016-2027) Figure 31. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2016-2027) Figure 32. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2016-2027) Figure 33. Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2016-2027) Figure 41. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2016-2027) Figure 42. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Region (2016-2027) Figure 43. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2016-2027) Figure 51. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2016-2027) Figure 52. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2016-2027) Figure 53. Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2016-2027) Figure 57. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2016-2027) Figure 58. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2016-2027) Figure 59. Turkey HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Adcock Ingram Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 63. Affine Formulations Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 64. Aurobindo Pharma Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 65. Biocon Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 66. Bristol-Myers Squibb Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 67. Cipla Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 68. Emcure Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 69. Flamingo Pharmaceuticals Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 70. Gilead Sciences Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 71. Hetero Drugs Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 72. IPCA Laboratories Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 73. Janssen Pharmaceutica (Johnson & Johnson) Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 74. LAURUS Labs Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 75. Medisist Pharma Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 76. Merck Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 77. Mylan Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 78. Ranbaxy Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 79. Shanghai Desano Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 80. ViiV Healthcare (GSK) Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) Figure 81. Bottom-up and Top-down Approaches for This Report Figure 82. Data Triangulation Figure 83. Key Executives Interviewed

Adcock Ingram Limited Affine Formulations Limited Aurobindo Pharma Biocon Limited Bristol-Myers Squibb Cipla Emcure Pharmaceuticals Flamingo Pharmaceuticals Limited Gilead Sciences Hetero Drugs IPCA Laboratories Janssen Pharmaceutica (Johnson & Johnson) LAURUS Labs Medisist Pharma Merck Mylan Ranbaxy Pharmaceuticals Shanghai Desano Pharmaceuticals ViiV Healthcare (GSK)